# US 2017/0281718 A1 · Antimicrobial peptide stimulating sanitizing composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281718 A1
- Document ID: US20170281718A1
- Status: Published application
- Kind: A1
- Application number: 15/476,099
- Filed: 2017-03-31
- Published: 2017-10-05
- Earliest claimed: 2016-03-31
- Assignees: GOJO Industries, Inc.
- Applicants: GOJO Industries, Inc.
- Inventors: Kegui Tian; Jessica Rae Tittl
- Web page: https://patentgrep.com/patent/US20170281718A1

## CPC

- A61K 38/08: Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A01N 31/02: Acyclic compounds
- A61K 8/34: Alcohols
- A61K 8/97: from algae, fungi, lichens or plants; from derivatives thereof
- A61K 36/55: Linaceae (Flax family), e.g. Linum
- A61K 38/07: Tetrapeptides
- A61P 31/04: Antibacterial agents
- A61P 37/04: Immunostimulants
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61Q 17/005: {Antimicrobial preparations}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

A method of increasing antimicrobial peptide concentration on the skin is provided. The method includes cleaning skin with at least one of a cleanser and a sanitizer and applying a topical composition to the skin. The topical composition is comprised of one or more polypeptides and natural extracts that increase the concentration of antimicrobial peptides.

## Claims

### Claim 1

A topical sanitizing composition for stimulating the production of antimicrobial peptides, said composition comprising;
about 0.02 wt. % to about 10.0 wt.% of an active ingredient;
at least about 40 wt. % of one or more C1-6 alcohols; and water, wherein said active ingredient comprises one or more of a natural extract and a polypeptide, where said topical composition increases the concentration of antimicrobial peptides, as compared to an otherwise identical topical composition without the active ingredient.

### Claim 2 (depends on 1)

The topical sanitizing composition of claim 1, wherein said natural extract is one or more of a plant extract, a seed extract and a fruit extract.

### Claim 3 (depends on 1)

The topical sanitizing composition of claim 1, wherein said natural extract is a seed extract.

### Claim 4 (depends on 3)

The topical sanitizing composition of claim 3, wherein said seed extract is at least one of linseed extract, flaxseed extract, hemp seed extract, grape seed extract, and grapefruit seed extract.

### Claim 5 (depends on 4)

The topical sanitizing composition of claim 4, wherein said seed extract is a linseed extract.

### Claim 6 (depends on 1)

The topical sanitizing composition of claim 1, wherein said active ingredient is a polypeptide.

### Claim 7 (depends on 6)

The topical sanitizing composition of claim 6, wherein said polypeptide is at least one of an oligopeptide and a hexapeptide.

### Claim 8 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical sanitizing composition comprises about 0.05 to about 5.0 wt. % active ingredient, based on the weight of the total composition.

### Claim 9 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical sanitizing composition comprises about 0.1 to about 1.0 wt. % active ingredient, based on the weight of the total composition.

### Claim 10 (depends on 1)

The topical sanitizing composition of claim 1, wherein said C1-6 alcohol is one or more of methanol, ethanol, propanol, butanol, pentanol, hexanol, and isomers and mixtures thereof.

### Claim 11 (depends on 1)

The topical sanitizing composition of claim 1, where said C1-6 alcohol is present in an amount above about 70 wt. %, based on the weight of the total composition.

### Claim 12 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition comprises one or more humectants, selected from the group consisting of propylene glycol, hexylene glycol, 1,4-dihydroxyhexane, 1,2,6-hexanetriol, sorbitol, butylene glycol, caprylyl glycol, propanediols, such as methyl propane diol, dipropylene glycol, triethylene glycol, glycerin (glycerol), polyethylene glycols, ethoxydiglycol, polyethylene sorbitol, and combinations thereof.

### Claim 13 (depends on 12)

The topical sanitizing composition of claim 12, wherein said humectant comprises one or more of caprylyl glycol and glycerin.

### Claim 14 (depends on 12)

The topical sanitizing composition of claim 12, wherein said humectant is present in an amount up to about 20.0 wt. %, based on the weight of the total composition.

### Claim 15 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition comprises one or more moisturizing esters, selected from the group consisting of cetyl myristate, cetyl myristoleate, and other cetyl esters, diisopropyl sebacate, isopropyl myristate, and combinations thereof.

### Claim 16 (depends on 15)

The topical sanitizing composition of claim 15, wherein said moisturizing ester is present in an amount up to about 10.0 wt. %, based on the weight of the total composition.

### Claim 17 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition increases antimicrobial peptide concentration by a statistically significant amount, as compared to an otherwise identical composition without the active ingredient.

### Claim 18 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition increases the concentration of HBD-1 by at least about 20%, relative to an otherwise identical topical composition without said active ingredient.

### Claim 19 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition increases the concentration of HBD-2 by at least about 7%, relative to an otherwise identical topical composition without said active ingredient.

### Claim 20 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition increases the concentration of HBD-3 by at least about 18%, relative to an otherwise identical topical composition without said active ingredient.

### Claim 21 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition increases the concentration of LL-37 by at least about 32%, relative to an otherwise identical topical composition without said active ingredient.

### Claim 22 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition decreases the concentration of IL-8 by at least about 30%, relative to an otherwise identical topical composition without said active ingredient.

### Claim 23 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition increases the concentration of HBD-1 by at least about 4 pg/mL, relative to an otherwise identical topical composition without said active ingredient.

### Claim 24 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition increases the concentration of HBD-2 by at least about 4 pg/mL, relative to an otherwise identical topical composition without said active ingredient.

### Claim 25 (depends on 1)

The topical sanitizing composition of claim 1, wherein said topical composition increases the concentration of HBD-3 by at least about 1 pg/mL, relative to an otherwise identical topical composition without said active ingredient.

### Claim 26

A method of skin treatment to increase the production of antimicrobial peptides on the skin, said method comprising:
applying a topical sanitizing composition to a skin surface, wherein said topical composition comprises:
about 0.02 wt. % to about 10.0 wt. % of an active ingredient;
at least about 40 wt. % of one or more C1-6 alcohols; and
the balance up to 100 wt. % being water, wherein said active ingredient comprises one or more of a natural extract and a polypeptide, where said topical composition increases the concentration of antimicrobial peptides on skin, as compared to an otherwise identical topical sanitizing composition without the active ingredient.

### Claim 27

A skin treatment composition comprising;
about 0.02 wt. % to about 10.0 wt. % of an active ingredient comprising one or more of a natural extract and a polypeptide;
about 40.0 wt. % to about 95.0 wt.% of one or more C1-6 alcohols;
about 0.01 wt. % to about 10.0 wt.% of a humectant;
about 0.01 wt. % to about 5.0 wt. % of a moisturizing ester; and
the balance up to 100 wt. % being water.

### Claim 28

A topical composition for increasing the innate immunity of the skin comprising;
about 0.02 wt. % to about 10.0 wt. % of an active ingredient comprising one or more of a natural extract and a polypeptide;
about 40.0 wt. % to about 95.0 wt. % of one or more C1-6 alcohols;
about 0.01 wt. % to about 5.0 wt. % of an emollient;
about 0.01 wt. % to about 5.0 wt. % of a viscosity modifier; and
water.

### Claim 29

A topical composition for increasing the innate immunity of the skin comprising;
about 0.02 wt. % to about 10.0 wt. % of an active ingredient comprising one or more of a natural extract and a polypeptide;
about 40.0 wt. % to about 95.0 wt. % of one or more C1-6 alcohols;
about 0.01 wt. % to about 5.0 wt. % of a foaming agent;
about 0.01 wt. % to about 10.0 wt. % of a humectant; and
water.
